Resultados de la búsqueda

Salloum FN, Tocchetti CG, Ameri P, Ardehali H, Asnani A, de Boer RA, Burridge P, Cabrera JÁ, de Castro J, Córdoba R, Costa A, Dent S, Engelbertsen D, Fernández-Velasco M, Fradley M, Fuster JJ, Galán-Arriola C, García-Lunar I, Ghigo A, González-Neira A, Hirsch E, Ibáñez B, Kitsis RN, Konety S, Lyon AR, Martin P, Mauro AG, Mazo Vega MM, Meijers WC, Neilan TG, Rassaf T, Ricke-Hoch M, Sepulveda P, Thavendiranathan P, van der Meer P, Fuster V, Ky B, López-Fernández T; International Cardio-Oncology Society. Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol (2023) 5:715-731.
Link to the full text in Repisalud

Díez-Díez M, Fuster JJ Troublemaking mutations: Clonal hematopoiesis for the prediction of prognosis in ST-segment elevation myocardial infarction. EBioMedicine (2022) 79

Matesanz N, Viana-Huete V, Zuriaga MA, Zorita V, Ferrer-Perez A, Amoros-Perez M, Carriero R, Kunderfranco P, Greco CM, Fuster JJ. TP53-MUTANT CLONAL HEMATOPOIESIS ACCELERATES EXPERIMENTAL ATHEROSCLEROSIS DEVELOPMENT Atherosclerosis (2022) 355

Amoros-Perez M, Zorita V, Moro-Moro R, Matesanz N, Viana-Huete V, Ferrer-Perez A, Fuster JJ. NO EFFECT OF RADIATION-RELATED CLONAL HEMATOPOIESIS DRIVEN BY PPM1D MUTATIONS ON EXPERIMENTAL ATHEROSCLEROSIS DEVELOPMENT Atherosclerosis (2022) 355:E125-E125

Yoshida Y, Shimizu I, Shimada A, Nakahara K, Yanagisawa S, Kubo M, Fukuda S, Ishii C, Yamamoto H, Ishikawa T, Kano K, Aoki J, Katsuumi G, Suda M, Ozaki K, Yoshida Y, Okuda S, Ohta S, Okamoto S, Minokoshi Y, Oda K, Sasaoka T, Abe M, Sakimura K, Kubota Y, Yoshimura N, Kajimura S, Zuriaga M, Walsh K, Soga T, Minamino T. Brown adipose tissue dysfunction promotes heart failure via a trimethylamine N-oxide-dependent mechanism. Sci Rep (2022) 12
Link to the full text in Repisalud

Fuster JJ. Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors. Thromb Res (2022) 213:S107-S112

Tall AR, Fuster JJ. Clonal hematopoiesis in cardiovascular disease and therapeutic implications. Nature Cardiovascular Research (2022) 1:116-124
Link to the full text in Repisalud

Pascual-Figal DA, Bayes-Genis A, Díez-Díez M, Hernández-Vicente Á, Vázquez-Andrés D, de la Barrera J, Vazquez E, Quintas A, Zuriaga MA, Asensio-López MC, Dopazo A, Sánchez-Cabo F, Fuster JJ Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction J Am Coll Cardiol (2021) 77:1747-1759

Fuster JJ Clonal Hematopoiesis and Incident Heart Failure Risk: The Clone Wars J Am Coll Cardiol (2021) 78:53-55

Palomo L, Santiago-Vacas E, Pascual-Figal D, Fuster JJ, Solé F, Bayés-Genís A Prevalence and characteristics of clonal hematopoiesis in heart failure Rev Esp Cardiol (2021) 74:996-999